Jacson Shen

2.6k total citations
52 papers, 2.0k citations indexed

About

Jacson Shen is a scholar working on Molecular Biology, Oncology and Cancer Research. According to data from OpenAlex, Jacson Shen has authored 52 papers receiving a total of 2.0k indexed citations (citations by other indexed papers that have themselves been cited), including 26 papers in Molecular Biology, 23 papers in Oncology and 15 papers in Cancer Research. Recurrent topics in Jacson Shen's work include MicroRNA in disease regulation (10 papers), Sarcoma Diagnosis and Treatment (9 papers) and Drug Transport and Resistance Mechanisms (8 papers). Jacson Shen is often cited by papers focused on MicroRNA in disease regulation (10 papers), Sarcoma Diagnosis and Treatment (9 papers) and Drug Transport and Resistance Mechanisms (8 papers). Jacson Shen collaborates with scholars based in United States, China and Japan. Jacson Shen's co-authors include Francis J. Hornicek, Zhenfeng Duan, Henry J. Mankin, Edwin Choy, Zhenfeng Duan, Yan Gao, Gregory M. Coté, David C. Harmon, Yong Feng and Quancheng Kan and has published in prestigious journals such as PLoS ONE, Scientific Reports and ACS Applied Materials & Interfaces.

In The Last Decade

Jacson Shen

51 papers receiving 2.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jacson Shen United States 28 981 689 617 523 237 52 2.0k
Maya Kansara Australia 14 1.3k 1.3× 574 0.8× 580 0.9× 631 1.2× 181 0.8× 31 2.2k
Kamalesh K. Sankhala United States 21 838 0.9× 797 1.2× 694 1.1× 194 0.4× 185 0.8× 77 1.8k
Pierrick G.J. Fournier United States 26 1.1k 1.1× 1.7k 2.5× 498 0.8× 415 0.8× 150 0.6× 37 2.8k
Nicholas Willumsen Denmark 26 609 0.6× 811 1.2× 330 0.5× 455 0.9× 142 0.6× 82 2.0k
Ymera Pignochino Italy 19 610 0.6× 818 1.2× 788 1.3× 302 0.6× 132 0.6× 48 1.7k
Tilly Aalders Netherlands 17 932 1.0× 405 0.6× 969 1.6× 563 1.1× 132 0.6× 29 1.9k
Silvia Calabuig‐Fariñas Spain 26 753 0.8× 577 0.8× 820 1.3× 678 1.3× 88 0.4× 78 1.9k
Erlinda M. Gordon United States 35 1.3k 1.3× 951 1.4× 411 0.7× 196 0.4× 90 0.4× 154 3.1k
Marc Baud’huin France 26 1.2k 1.2× 706 1.0× 200 0.3× 314 0.6× 201 0.8× 50 2.1k
Bruno Fuchs Switzerland 31 876 0.9× 442 0.6× 582 0.9× 478 0.9× 182 0.8× 64 2.2k

Countries citing papers authored by Jacson Shen

Since Specialization
Citations

This map shows the geographic impact of Jacson Shen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jacson Shen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jacson Shen more than expected).

Fields of papers citing papers by Jacson Shen

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jacson Shen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jacson Shen. The network helps show where Jacson Shen may publish in the future.

Co-authorship network of co-authors of Jacson Shen

This figure shows the co-authorship network connecting the top 25 collaborators of Jacson Shen. A scholar is included among the top collaborators of Jacson Shen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jacson Shen. Jacson Shen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Zhou, Yubing, Jacson Shen, Zujiang Yu, et al.. (2018). Expression and therapeutic implications of cyclin-dependent kinase 4 (CDK4) in osteosarcoma. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease. 1864(5). 1573–1582. 54 indexed citations
2.
Liu, Pei, et al.. (2017). Wnt inhibitory factor 1 (WIF1) methylation and its association with clinical prognosis in patients with chondrosarcoma. Scientific Reports. 7(1). 1580–1580. 16 indexed citations
3.
Gao, Yan, Jacson Shen, Edwin Choy, et al.. (2017). Inhibition of CDK4 sensitizes multidrug resistant ovarian cancer cells to paclitaxel by increasing apoptosiss. Cellular Oncology. 40(3). 209–218. 27 indexed citations
4.
Gao, Yan, Yunfei Liao, Jacson Shen, et al.. (2016). Evaluation of P‐glycoprotein (Pgp) expression in human osteosarcoma by high‐throughput tissue microarray. Journal of Orthopaedic Research®. 34(9). 1606–1612. 14 indexed citations
5.
Min, Li, Jacson Shen, Chongqi Tu, Francis J. Hornicek, & Zhenfeng Duan. (2016). The roles and implications of exosomes in sarcoma. Cancer and Metastasis Reviews. 35(3). 377–390. 37 indexed citations
6.
Shen, Jacson, Gregory M. Coté, Yan Gao, et al.. (2016). Targeting EZH2-mediated methylation of H3K27 inhibits proliferation and migration of Synovial Sarcoma in vitro. Scientific Reports. 6(1). 25239–25239. 49 indexed citations
7.
Ren, Fang, Jacson Shen, Huirong Shi, et al.. (2016). Novel mechanisms and approaches to overcome multidrug resistance in the treatment of ovarian cancer. Biochimica et Biophysica Acta (BBA) - Reviews on Cancer. 1866(2). 266–275. 88 indexed citations
8.
Gao, Yan, Jacson Shen, Edwin Choy, et al.. (2016). Pharmacokinetics and tolerability of NSC23925b, a novel P-glycoprotein inhibitor: preclinical study in mice and rats. Scientific Reports. 6(1). 25659–25659. 14 indexed citations
9.
Li, Jingyuan, et al.. (2016). The Roles of Sox Family Genes in Sarcoma. Current Drug Targets. 17(15). 1761–1772. 21 indexed citations
10.
Yang, Xiaoqian, Yong Feng, Yan Gao, et al.. (2015). NSC23925 prevents the emergence of multidrug resistance in ovarian cancer in vitro and in vivo. Gynecologic Oncology. 137(1). 134–142. 10 indexed citations
11.
Yang, Xiaoqian, et al.. (2015). Quantitative analysis of left atrial volume and function during normotensive and preeclamptic pregnancy: a real-time three-dimensional echocardiography study. International journal of cardiac imaging. 31(4). 805–812. 27 indexed citations
12.
Feng, Yong, Jacson Shen, Yan Gao, et al.. (2015). Expression of programmed cell death ligand 1 (PD-L1) and prevalence of tumor-infiltrating lymphocytes (TILs) in chordoma. Oncotarget. 6(13). 11139–11149. 83 indexed citations
13.
Liao, Yunfei, Yong Feng, Jacson Shen, Francis J. Hornicek, & Zhenfeng Duan. (2015). The roles and therapeutic potential of cyclin-dependent kinases (CDKs) in sarcoma. Cancer and Metastasis Reviews. 35(2). 151–163. 34 indexed citations
14.
Gao, Yan, Yong Feng, Jacson Shen, et al.. (2015). CD44 is a direct target of miR-199a-3p and contributes to aggressive progression in osteosarcoma. Scientific Reports. 5(1). 11365–11365. 77 indexed citations
15.
Ye, Shunan, Jacson Shen, Edwin Choy, et al.. (2015). p53 overexpression increases chemosensitivity in multidrug-resistant osteosarcoma cell lines. Cancer Chemotherapy and Pharmacology. 77(2). 349–356. 35 indexed citations
16.
Shen, Jacson, Gregory M. Coté, Edwin Choy, et al.. (2014). Programmed Cell Death Ligand 1 Expression in Osteosarcoma. Cancer Immunology Research. 2(7). 690–698. 154 indexed citations
17.
Choy, Edwin, Laura E. MacConaill, Gregory M. Coté, et al.. (2014). Genotyping Cancer-Associated Genes in Chordoma Identifies Mutations in Oncogenes and Areas of Chromosomal Loss Involving CDKN2A, PTEN, and SMARCB1. PLoS ONE. 9(7). e101283–e101283. 61 indexed citations
18.
Duan, Zhenfeng, Jianming Zhang, Shunan Ye, et al.. (2014). A-770041 reverses paclitaxel and doxorubicin resistance in osteosarcoma cells. BMC Cancer. 14(1). 681–681. 27 indexed citations
19.
Yang, Xiaoqian, Pei Yang, Jacson Shen, et al.. (2014). Prevention of multidrug resistance (MDR) in osteosarcoma by NSC23925. British Journal of Cancer. 110(12). 2896–2904. 45 indexed citations
20.
Shen, Jacson, Gregory M. Coté, Edwin Choy, Francis J. Hornicek, & Zhenfeng Duan. (2014). Targeting programmed cell death ligand 1 in osteosarcoma: an auto-commentary on therapeutic potential. OncoImmunology. 3(8). e954467–e954467. 12 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Maya Kansara Breakdown of academic impact, for papers by Kamalesh K. Sankhala Breakdown of academic impact, for papers by Pierrick G.J. Fournier Breakdown of academic impact, for papers by Nicholas Willumsen Breakdown of academic impact, for papers by Ymera Pignochino Breakdown of academic impact, for papers by Tilly Aalders Breakdown of academic impact, for papers by Silvia Calabuig‐Fariñas Breakdown of academic impact, for papers by Erlinda M. Gordon Breakdown of academic impact, for papers by Marc Baud’huin Breakdown of academic impact, for papers by Bruno Fuchs
Rankless by CCL
2026